Product Information
MEGESTROL ACET 40 MG/ML SUSP is a generic product labeled by Strides Pharma Inc., priced at $0.1290 per ML under NDC 64380016002. Its NADAC has been published 227 times since Jun 1, 2022.
FDA first approved this application on Jul 25, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/mL
Manufacturer
Strides Pharma Inc.NDC
64380016002
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MEGESTROL ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA075671FDA Approved
7/25/2001
TE Code
AB
On Market Since
3/21/2022
Pharmacological Classes
Price Statistics
The NADAC for MEGESTROL ACET 40 MG/ML SUSP has been published 227 times since Jun 1, 2022, and over the history we have for it it has risen 37.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1290 per ML |
|---|---|
| All-time high | $0.1399 (Mar 15, 2023) |
| All-time low | $0.0941 (Jun 1, 2022) |
| 52-week high | $0.1356 |
| 52-week low | $0.1237 |
| Median price | $0.1255 |
| Average price | $0.1228 |
| Largest weekly change | +19.0% (Feb 22, 2023) |
| Weeks tracked | 227 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Megestrol Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEGESTROL ACET 40 MG/ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for MEGESTROL ACET 40 MG/ML SUSP, manufactured by Strides Pharma Inc., is $0.1290 per ML (NDC 64380016002), effective Sep 30, 2026.
How has the price of MEGESTROL ACET 40 MG/ML SUSP changed over time?
Over the history we have for it, the NADAC for MEGESTROL ACET 40 MG/ML SUSP has risen 37.1%. It has been tracked across 227 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for MEGESTROL ACET 40 MG/ML SUSP?
Since Jun 1, 2022, the NADAC for MEGESTROL ACET 40 MG/ML SUSP has ranged from a low of $0.0941 (Jun 1, 2022) to a high of $0.1399 (Mar 15, 2023), with a median of $0.1255 per ML.
Are there cheaper alternatives to MEGESTROL ACET 40 MG/ML SUSP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MEGESTROL ACET 40 MG/ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures MEGESTROL ACET 40 MG/ML SUSP?
MEGESTROL ACET 40 MG/ML SUSP (NDC 64380016002) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.